The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Carbon nanostructures as multi-functional drug delivery platforms
Abstract
Nanotechnology is providing exciting and new opportunities which are likely to revolutionize future clinical practice. The use of nanoparticles for biomedical applications is particularly exciting due to their huge potential for multi-modal approaches. This includes their use as drug delivery vectors, imaging contrast agents, hyperthermia systems and molecular targeting. Their ability to cross biological barriers, for example the blood brain barrier, makes them attractive for potential treatments in neurological disorders. There is also great hope that nanostructures will serve as platforms in future cancer therapies. Current cancer fighting strategies consist primarily of surgery, radiation therapy and chemotherapy. Each of these treatments is bound by a limit, known as the therapeutic window, which, if exceeded, causes undue harm to the patient. In the ongoing quest to improve our therapeutic arsenal, nanoparticles are emerging as exciting structures for a new generation of multi-modal therapeutics. Within this context, carbon nanostructures are amongst the leading contenders as building blocks to deliver multi-function drug delivery platforms. This review examines the various properties of carbon nanostructures that allow such multi-functionality. Recent advances on the development of novel approaches for functionalization, targeting and imaging via carbon nanostructures are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Two-dimensional gas of massless Dirac fermions in graphene
Novoselov, K. S., Geim, A. K., Morozov, S. V., Jiang, D., Katsnelson, M. I., Grigorieva, I. V., Dubonos, S. V., & Firsov, A. A. (2005) · Nature · doi:10.1038/nature04233 · Cited by 21,611
Hydrogels for tissue engineering: scaffold design variables and applications
Drury, J. L., & Mooney, D. J. (2003) · Biomaterials · doi:10.1016/s0142-9612(03)00340-5 · Cited by 5,136
Poland, C. A., Duffin, R., Kinloch, I., Maynard, A., Wallace, W. A. H., Seaton, A., Stone, V., Brown, S., MacNee, W., & Donaldson, K. (2008) · Nature Nanotechnology · doi:10.1038/nnano.2008.111 · Cited by 2,645
Hussain, S. P., Hofseth, L. J., & Harris, C. C. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1046 · Cited by 1,690
Carbon nanotube coating improves neuronal recordings
Keefer, E. W., Botterman, B. R., Romero, M. I., Rossi, A. F., & Gross, G. W. (2008) · Nature Nanotechnology · doi:10.1038/nnano.2008.174 · Cited by 721
Using Graphene Oxide High Near‐Infrared Absorbance for Photothermal Treatment of Alzheimer's Disease
Li, M., Yang, X., Ren, J., Qu, K., & Qu, X. (2012) · Advanced Materials · doi:10.1002/adma.201104864 · Cited by 535
Fullerene-based antioxidants and neurodegenerative disorders.
Dugan, L. L., Lovett, E. G., Quick, K. L., Lotharius, J., Lin, T. T., & O'Malley, K. L. (2001) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(00)00064-x · Cited by 338
Multimodal optical sensing and analyte specificity using single-walled carbon nanotubes
Heller, D. A., Jin, H., Martinez, B. M., Patel, D., Miller, B. M., Yeung, T.-K., Jena, P. V., Höbartner, C., Ha, T., Silverman, S. K., et al. (2009) · Nature Nanotechnology · doi:10.1038/nnano.2008.369 · Cited by 319
Yang, Z., Zhang, Y., Yang, Y., Sun, L., Han, D., Li, H., & Wang, C. (2010) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2009.11.007 · Cited by 311
Yan, A., Von Dem Bussche, A., Kane, A. B., & Hurt, R. H. (2007) · Carbon · doi:10.1016/j.carbon.2007.08.035 · Cited by 95
Cited by
Nanomaterials: a review of synthesis methods, properties, recent progress, and challenges
Baig, N., Kammakakam, I., & Falath, W. (2021) · Materials Advances · doi:10.1039/d0ma00807a · Cited by 3,262
Science and technology roadmap for graphene, related two-dimensional crystals, and hybrid systems
Ferrari, A. C., Bonaccorso, F., Fal'ko, V., Novoselov, K. S., Roche, S., Bøggild, P., Borini, S., Koppens, F. H. L., Palermo, V., Pugno, N., et al. (2015) · Nanoscale · doi:10.1039/c4nr01600a · Cited by 3,027
Metal–Organic Framework (MOF)‐Based Drug/Cargo Delivery and Cancer Therapy
Wu, M., & Yang, Y. (2017) · Advanced Materials · doi:10.1002/adma.201606134 · Cited by 2,285
Graphene and graphene oxide as new nanocarriers for drug delivery applications
Liu, J., Cui, L., & Losic, D. (2013) · Acta Biomaterialia · doi:10.1016/j.actbio.2013.08.016 · Cited by 1,343
Recent Advancement of Nanostructured Carbon for Energy Applications
Yang, Z., Ren, J., Zhang, Z., Chen, X., Guan, G., Qiu, L., Zhang, Y., & Peng, H. (2015) · Chemical Reviews · doi:10.1021/cr5006217 · Cited by 810
Metadata
- Authors
- Mendes, R. G., Bachmatiuk, A., Büchner, B., Cuniberti, G., & Rümmeli, M. H.
- Venue
- J. Mater. Chem. B
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2013
- Volume
- 1
- Issue
- 4
- Pages
- 401-428
- ISSN
- 2050-750X (ISSN-L)
- 2050-7518
- OpenAlex
- W2154637181
- Cited by
- 229
- References
- 10
- FWCI
- 8.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.